Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its pr...
Synovics Pharmaceuticals reported revenue of $25.96 million for fiscal year 2008, up 10.6% from fiscal year 2007, and net income of -$4.01 million. In Q3 2009 (the quarter ended July 31, 2009) revenue was $1.58 million, down 79.5% from a year before. Its market capitalization was $542,858 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended October 31, 2008; market data as of October 8, 2026.
No profile data available.